Wells Fargo raises Morgan Stanley target to $225

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Wells Fargo analyst Mike Mayo maintained an Equal-Weight rating on Morgan Stanley (NYSE: MS) while increasing the price target to $225 from $200.

powered bylight_fuzz_icon
43857240

*this image is generated using AI for illustrative purposes only.

Wells Fargo analyst Mike Mayo has raised the price target for Morgan Stanley (NYSE: MS) to $225, up from the previous $200, while maintaining an Equal-Weight rating on the stock. The adjustment reflects a revised valuation outlook for the financial services firm.

Rating and Target Details

The Equal-Weight rating suggests that Morgan Stanley's stock is expected to perform in line with the broader market or sector average. The new price target of $225 represents an increase over the prior target of $200, indicating a more optimistic view on the stock's potential upside.

Metric Value
Rating Equal-Weight
Previous Price Target $200
New Price Target $225

The revised target provides investors with a specific benchmark for the stock's performance over the near term.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Wells Fargo to revise Morgan Stanley's valuation outlook?

How might Morgan Stanley's recent performance compare to its competitors in the financial sector?

What potential risks could impact Morgan Stanley's ability to meet the new $225 price target?

like16
dislike

Citigroup maintains Neutral on Morgan Stanley, raises target to $220

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Citigroup analyst Keith Horowitz maintains a Neutral rating on Morgan Stanley (NYSE: MS) and raises the price target to $220 from $194.

powered bylight_fuzz_icon
43779398

*this image is generated using AI for illustrative purposes only.

Citigroup analyst Keith Horowitz has maintained a Neutral rating on Morgan Stanley (NYSE: MS) while raising the price target for the stock. The new target is set at $220, an increase from the previous $194.

The adjustment reflects a revised outlook on the financial services firm's valuation. The Neutral rating suggests that the stock is expected to perform in line with the broader market.

Metric Value
Rating Neutral
Previous Price Target $194
New Price Target $220
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Citigroup to revise Morgan Stanley's valuation outlook?

How might Morgan Stanley's recent performance influence other analysts' ratings?

What potential market conditions could shift Morgan Stanley's stock from Neutral to a Buy or Sell?

like18
dislike

More News on Morgan Stanley